Evidence map›Paper›PMID 31319475›Full record

ArticleMolecules (Basel, Switzerland)2019

Competitive Protein Binding Assay of Naproxen by Human Serum Albumin Functionalized Silicon Dioxide Nanoparticles.

Qian-Long Wang, Jing Xie, Jian Liang, Geng-Ting Dong, Li-Sheng Ding, Pei Luo, Lin-Sen Qing

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Qian-Long WangSchool of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
Jing XieSchool of Pharmacy, Chengdu Medical College, Chengdu 610500, China.
Jian LiangChengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Geng-Ting DongState Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China.
Li-Sheng DingChengdu Institute of Biology, Chinese Academy of Sciences, Chengdu 610041, China.
Pei LuoState Key Laboratory for Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China. pluo@must.edu.mo.
Lin-Sen QingSchool of Pharmacy, Chengdu Medical College, Chengdu 610500, China. qingls@cib.ac.cn.ORCID 0000-0002-9685-9180
Macau University of Science and Technology · MOChinese Academy of Sciences · CN

Funding

the Chinese Academy of Sciences (CAS) 'Light of West China' Program 2018XBZG_XBQNXZ_A_005the Macao Science and Technology Development Fund 052/2013/A2
6 · The paper itself

Abstract

We have developed a new competitive protein binding assay (CPBA) based on human serum albumin functionalized silicon dioxide nanoparticles (nano-SiO

Indexed as

Horseradish PeroxidaseHumansHydrogen PeroxideLimit of DetectionNanoparticlesNanostructuresNaproxenProtein BindingSerum Albumin, HumanSilicon DioxideHorseradish PeroxidaseHydrogen PeroxideNaproxenSerum Albumin, HumanSilicon Dioxidecompetitive protein binding assayhorseradish peroxidase labeled naproxennaproxen

Identifiers

PMID31319475
PMCPMC6680384
OpenAlexW2960864546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.